UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An evaluation of spectral and statistical parameters of ion pair complexation of Zafirlukast using chromogenic dyes in solid dispersion-based formulations

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2023-12, Vol.302, p.123049, Article 123049

2023

Volltextzugriff (PDF)

Leukotriene-modifying agents may increase the risk of depression: A cross-sectional study

Journal of affective disorders, 2024-07, Vol.356, p.728-736

2024

Volltextzugriff (PDF)

Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials

Journal of allergy and clinical immunology, 2024-10, Vol.154 (4), p.996-1007

2024

Volltextzugriff (PDF)

Zafirlukast protects against hepatic ischemia–reperfusion injury in rats via modulating Bcl-2/Bax and NF-κB/SMAD-4 pathways

International immunopharmacology, 2023-09, Vol.122, p.110498-110498, Article 110498

2023

Volltextzugriff (PDF)

Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity

The Journal of biological chemistry, 2022-03, Vol.298 (3), p.101731-101731, Article 101731

2022

Volltextzugriff (PDF)

Cysteinyl leukotriene receptor type 1 (CysLT1R) antagonist zafirlukast protects against TNF-α-induced endothelial inflammation

Biomedicine & pharmacotherapy, 2019-03, Vol.111, p.452-459

2019

Volltextzugriff (PDF)

Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor

European journal of medicinal chemistry, 2018-09, Vol.157, p.1202-1213

2018

Volltextzugriff (PDF)

Small scale in vitro method to determine a potential bioequivalent equilibrium solubility range for fed human intestinal fluid

European journal of pharmaceutics and biopharmaceutics, 2022-08, Vol.177, p.126-134

2022

Volltextzugriff (PDF)

FORMULATION DEVELOPMENT AND EVALUATION OF CHRONOMODULATED DRUG DELIVERY SYSTEM BY ZAFIRLUKAST

International journal of applied pharmaceutics, 2021-07, p.211-220

2021

Volltextzugriff (PDF)

Effects of Oral Zafirlukast, Sildenafil, or Pirfenidone on the Formation of Postsurgical Intra-Abdominal Adhesions in an Experimental Rat Model

European surgical research, 2022-09, Vol.63 (3), p.145-154

2022

Volltextzugriff (PDF)

Choline-Amino Acid-Derived Bio-ionic Liquids for Solubility Enhancement of Zafirlukast

AAPS PharmSciTech, 2022-05, Vol.23 (5), p.146-146, Article 146

2022

Volltextzugriff (PDF)

Cysteinyl leukotriene receptor 1 is a potent regulator of the endosomal‐lysosomal system in the ARPE‐19 retinal pigment epithelial cell line

Traffic (Copenhagen, Denmark), 2023-04, Vol.24 (4), p.177-189

2023

Volltextzugriff (PDF)

Zafirlukast is a broad‐spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times

British journal of pharmacology, 2021-02, Vol.178 (3), p.550-563

2021

Volltextzugriff (PDF)

Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid

European journal of pharmaceutics and biopharmaceutics, 2021-11, Vol.168, p.90-96

2021

Volltextzugriff (PDF)

A SWELL time to develop the molecular pharmacology of the volume-regulated anion channel (VRAC)

Channels (Austin, Tex.), 2022-12, Vol.16 (1), p.27-36

2022

Volltextzugriff (PDF)

Competitive Analysis of the Binding Affinity of Montelukast, Zafirlukast and Gemilukast to CysLTR1, P2Y12 and PPAR-γ and their Possible Cardioprotective Effect: Using in silico Methods

Journal of pharmacology & pharmacotherapeutics, 2024-03, Vol.15 (1), p.28-37

2024

Volltextzugriff (PDF)

Zafirlukast and vincamine ameliorate tamoxifen-induced oxidative stress and inflammation: Role of the JNK/ERK pathway

Life sciences (1973), 2018-06, Vol.202, p.78-88

2018

Volltextzugriff (PDF)

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ

Frontiers in pharmacology, 2019-03, Vol.10, p.263-263

2019

Volltextzugriff (PDF)

Cysteinyl Leukotriene Pathway and Cancer

International journal of molecular sciences, 2021-12, Vol.23 (1), p.120

2021

Volltextzugriff (PDF)

Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung

International journal of molecular sciences, 2022-10, Vol.23 (20), p.12221

2022

Volltextzugriff (PDF)

Encapsulation and release of Zafirlukast from electrospun polyisobutylene-based thermoplastic elastomeric fiber mat

European polymer journal, 2018-01, Vol.98, p.254-261

2018

Volltextzugriff (PDF)

Sensitive electroanalytical assay, evaluation of thermodynamic and mechanism parameters of leukotriene receptor antagonist Zafirlucast

Sensors and actuators. B, Chemical, 2020-10, Vol.320, p.128251, Article 128251

2020

Volltextzugriff (PDF)

Zafirlukast protects blood-brain barrier integrity from ischemic brain injury

Chemico-biological interactions, 2020-01, Vol.316, p.108915-108915, Article 108915

2020

Volltextzugriff (PDF)

Zafirlukast attenuates advanced glycation end-products (AGEs)-induced degradation of articular extracellular matrix (ECM)

International immunopharmacology, 2019-03, Vol.68, p.68-73

2019

Volltextzugriff (PDF)

The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)

Journal of infection and public health, 2022-12, Vol.15 (12), p.1546-1550

2022

Volltextzugriff (PDF)

1 – 25 von 221

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(197)
Mit Volltextzugriff
(188)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Zafirlukast
(218)
Science & Technology
(168)
Life Sciences & Biomedicine
(159)
Humans
(110)
Asthma
(85)
Biological And Medical Sciences
(71)
Medical Sciences
(70)
Male
(67)
Montelukast
(65)
Asthma - Drug Therapy
(62)
Pharmacology & Pharmacy
(61)
Pharmacology. Drug Treatments
(61)
Female
(56)
Leukotriene Antagonists - Therapeutic Use
(54)
Adult
(51)
Tosyl Compounds - Therapeutic Use
(51)
Respiratory System
(44)
Middle Aged
(43)
Anti-Asthmatic Agents - Therapeutic Use
(39)
Animals
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

An evaluation of spectral and statistical parameters of ion pair complexation of Zafirlukast using chromogenic dyes in solid dispersion-based formulations

Leukotriene-modifying agents may increase the risk of depression: A cross-sectional study

Leukotriene receptor antagonists as add-on therapy to antihistamines for urticaria: Systematic review and meta-analysis of randomized clinical trials

Zafirlukast protects against hepatic ischemia–reperfusion injury in rats via modulating Bcl-2/Bax and NF-κB/SMAD-4 pathways

Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity

Cysteinyl leukotriene receptor type 1 (CysLT1R) antagonist zafirlukast protects against TNF-α-induced endothelial inflammation

Breathing new life into West Nile virus therapeutics; discovery and study of zafirlukast as an NS2B-NS3 protease inhibitor

Small scale in vitro method to determine a potential bioequivalent equilibrium solubility range for fed human intestinal fluid

FORMULATION DEVELOPMENT AND EVALUATION OF CHRONOMODULATED DRUG DELIVERY SYSTEM BY ZAFIRLUKAST

Effects of Oral Zafirlukast, Sildenafil, or Pirfenidone on the Formation of Postsurgical Intra-Abdominal Adhesions in an Experimental Rat Model

Choline-Amino Acid-Derived Bio-ionic Liquids for Solubility Enhancement of Zafirlukast

Cysteinyl leukotriene receptor 1 is a potent regulator of the endosomal‐lysosomal system in the ARPE‐19 retinal pigment epithelial cell line

Zafirlukast is a broad‐spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times

Small scale in vitro method to determine a bioequivalent equilibrium solubility range for fasted human intestinal fluid

A SWELL time to develop the molecular pharmacology of the volume-regulated anion channel (VRAC)

Competitive Analysis of the Binding Affinity of Montelukast, Zafirlukast and Gemilukast to CysLTR1, P2Y12 and PPAR-γ and their Possible Cardioprotective Effect: Using in silico Methods

Zafirlukast and vincamine ameliorate tamoxifen-induced oxidative stress and inflammation: Role of the JNK/ERK pathway

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ

Cysteinyl Leukotriene Pathway and Cancer

Blockade of Platelet CysLT1R Receptor with Zafirlukast Counteracts Platelet Protumoral Action and Prevents Breast Cancer Metastasis to Bone and Lung

Encapsulation and release of Zafirlukast from electrospun polyisobutylene-based thermoplastic elastomeric fiber mat

Sensitive electroanalytical assay, evaluation of thermodynamic and mechanism parameters of leukotriene receptor antagonist Zafirlucast

Zafirlukast protects blood-brain barrier integrity from ischemic brain injury

Zafirlukast attenuates advanced glycation end-products (AGEs)-induced degradation of articular extracellular matrix (ECM)

The efficacy of Zafirlukast as a SARS-CoV-2 helicase inhibitor in adult patients with moderate COVID-19 Pneumonia (pilot randomized clinical trial)

Suchergebnisse filtern